164 related articles for article (PubMed ID: 31340709)
1. Development and characterization of octreotide-modified curcumin plus docetaxel micelles for potential treatment of non-small-cell lung cancer.
An Q; Shi CX; Guo H; Xie SM; Yang YY; Liu YN; Liu ZH; Zhou CZ; Niu FJ
Pharm Dev Technol; 2019 Nov; 24(9):1164-1174. PubMed ID: 31340709
[TBL] [Abstract][Full Text] [Related]
2. Drug-interactive mPEG-
Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
[TBL] [Abstract][Full Text] [Related]
3. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.
Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB
Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247
[TBL] [Abstract][Full Text] [Related]
4. Octreotide-modified polymeric micelles as potential carriers for targeted docetaxel delivery to somatostatin receptor overexpressing tumor cells.
Zhang Y; Wang X; Wang J; Zhang X; Zhang Q
Pharm Res; 2011 May; 28(5):1167-78. PubMed ID: 21340573
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of self-assembly Soluplus
Jiang S; Mou Y; He H; Yang D; Qin L; Zhang F; Zhang P
Drug Dev Ind Pharm; 2019 Nov; 45(11):1788-1798. PubMed ID: 31500443
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting tumour metastasis by DQA modified paclitaxel plus ligustrazine micelles in treatment of non-small-cell lung cancer.
Xie HJ; Zhao J; Zhuo-Ma D; Zhan-Dui N; Er-Bu A; Tsering T
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3465-3477. PubMed ID: 31432702
[TBL] [Abstract][Full Text] [Related]
7. α-Conotoxin ImI-modified polymeric micelles as potential nanocarriers for targeted docetaxel delivery to α7-nAChR overexpressed non-small cell lung cancer.
Mei D; Zhao L; Chen B; Zhang X; Wang X; Yu Z; Ni X; Zhang Q
Drug Deliv; 2018 Nov; 25(1):493-503. PubMed ID: 29426250
[TBL] [Abstract][Full Text] [Related]
8. Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer.
Wang X; Cheng L; Xie HJ; Ju RJ; Xiao Y; Fu M; Liu JJ; Li XT
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1154-1169. PubMed ID: 30043652
[TBL] [Abstract][Full Text] [Related]
9. Preparation and antitumor evaluation of hinokiflavone hybrid micelles with mitochondria targeted for lung adenocarcinoma treatment.
Chen Y; Feng X; Li L; Song K; Zhang L
Drug Deliv; 2020 Dec; 27(1):565-574. PubMed ID: 32252563
[TBL] [Abstract][Full Text] [Related]
10. Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer.
Wang B; Zhang W; Zhou X; Liu M; Hou X; Cheng Z; Chen D
Drug Deliv; 2019 Dec; 26(1):1265-1279. PubMed ID: 31777307
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a novel drug delivery: Soluplus
Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L
Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714
[TBL] [Abstract][Full Text] [Related]
13. Optimization and anticancer activity in vitro and in vivo of baohuoside I incorporated into mixed micelles based on lecithin and Solutol HS 15.
Yan HM; Song J; Zhang ZH; Jia XB
Drug Deliv; 2016 Oct; 23(8):2911-2918. PubMed ID: 26644047
[TBL] [Abstract][Full Text] [Related]
14. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
15. Novel T7-Modified pH-Responsive Targeted Nanosystem for Co-Delivery of Docetaxel and Curcumin in the Treatment of Esophageal Cancer.
Deng L; Zhu X; Yu Z; Li Y; Qin L; Liu Z; Feng L; Guo R; Zheng Y
Int J Nanomedicine; 2020; 15():7745-7762. PubMed ID: 33116498
[TBL] [Abstract][Full Text] [Related]
16. Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.
Jaskula-Sztul R; Xu W; Chen G; Harrison A; Dammalapati A; Nair R; Cheng Y; Gong S; Chen H
Biomaterials; 2016 Jun; 91():1-10. PubMed ID: 26994874
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer.
Zhu X; Yu Z; Feng L; Deng L; Fang Z; Liu Z; Li Y; Wu X; Qin L; Guo R; Zheng Y
Carbohydr Polym; 2021 Sep; 268():118237. PubMed ID: 34127219
[TBL] [Abstract][Full Text] [Related]
18. Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded mPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity.
Cheng WJ; Lin SY; Chen M; Chen LC; Ho HO; Chuang KH; Sheu MT
Int J Nanomedicine; 2021; 16():4017-4030. PubMed ID: 34140769
[TBL] [Abstract][Full Text] [Related]
19. Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis.
Liu L; Sun L; Wu Q; Guo W; Li L; Chen Y; Li Y; Gong C; Qian Z; Wei Y
Int J Pharm; 2013 Feb; 443(1-2):175-82. PubMed ID: 23287774
[TBL] [Abstract][Full Text] [Related]
20. Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-α-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment.
Wu H; Zhong Q; Zhong R; Huang H; Xia Z; Ke Z; Zhang Z; Song J; Jia X
Int J Nanomedicine; 2016; 11():6337-6352. PubMed ID: 27932881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
